Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: A systematic review of interventional studies

Journal of Diabetes and Metabolic Disorders

Volumn 14, Issue 1, 2015, Pages

  Nigil Haroon, Nisha ^a   Anton, Ammepa ^b   John, Jisha ^c   Mittal, Madhukar ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cholecalciferol; Glycemic control; Insulin sensitivity; Type 2 diabetes; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; HEMOGLOBIN A1C; VITAMIN D;

ARTICLE; CELL FUNCTION; CELLULAR SECRETION; DRUG EFFECT; FOLLOW UP; GLUCOSE CLAMP TECHNIQUE; GLYCEMIC CONTROL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIC EUGLYCEMIC CLAMP TECHNIQUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC PARAMETERS; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 84927708565     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/s40200-015-0130-9     Document Type: Article

References (49)

1. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009, 301(20):2129-40. 10.1001/jama.2009.726, 19470990.
2. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011, 34(6):1249-57. 10.2337/dc11-0442, 21617109.
3. Group UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-54. 10.1016/S0140-6736(05)61359-1.
4. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-86. 10.1056/NEJM199309303291401.
5. Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJM 2000, 93(6):369-74. 10.1093/qjmed/93.6.369, 10873187.
6. Montane J, Cadavez L, Novials A. Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab Syndr Obes 2014, 7:25-34. 24520198.
7. Faria HT, Santos MA, Arrelias CC, Rodrigues FF, Gonela JT, Teixeira CR, et al. Adherence to diabetes mellitus treatments in family health strategy units. Rev Esc Enferm USP 2014, 48(2):257-63. 10.1590/S0080-623420140000200009, 24918884.
8. Personne V, Partouche H, Souberbielle JC. Vitamin D insufficiency and deficiency: epidemiology, measurement, prevention and treatment. Presse Med 2013, 42(10):1334-42. 10.1016/j.lpm.2013.06.013, 24051167.
9. Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, et al. Meta-analysis of All-Cause Mortality According to Serum 25-Hydroxyvitamin D. Am J Public Health 2014, 12:e1-8.
10. Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A, et al. Vitamin D deficiency: a new risk factor for type 2 diabetes. Ann Nutr Metab 2012, 61(4):337. 10.1159/000342771, 23208163.
11. Huang Y, Yu H, Lu J, Guo K, Zhang L, Bao Y, et al. Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy. PLoS One 2012, 7(11):e50510. 10.1371/journal.pone.0050510, 23209764.
12. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011, 65(9):1005-15. 10.1038/ejcn.2011.118, 21731035.
13. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013, 36:1422-8. 10.2337/dc12-0962, 23613602.
14. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012, 29(8):e142-50. 10.1111/j.1464-5491.2012.03672.x, 22486204.
15. Strobel F, Reusch J, Penna-Martinez M, Ramos-Lopez E, Klahold E, Klepzig C, et al. Effect of a randomised controlled vitamin D trial on insulin resistance and glucose metabolism in patients with type 2 diabetes mellitus. Horm Metab Res 2014, 46(1):54-8. 24198221.
16. Alam U, Chan AW, Buazon A, Van Zeller C, Berry JL, Jugdey RS, et al. Differential effects of different vitamin D replacement strategies in patients with diabetes. J Diabet Complicat 2014, 28(1):66-70. 10.1016/j.jdiacomp.2013.09.003.
17. Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 2013, 32(6):970-5. 10.1016/j.clnu.2013.01.020, 23561637.
18. Bonakdaran S, Hami M, Hatefi A. The effects of calcitriol on albuminuria in patients with type-2 diabetes mellitus. Saudi J Kidney Dis Transpl 2012, 23(6):1215-20. 23168851.
19. Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 2013, 26(5(1):8. 10.1186/1758-5996-5-8.
20. Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, et al. Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 2012, 11:85. 10.1186/1475-2840-11-85, 22809461.
21. Heshmat R, Tabatabaei-Malazy O, Abbaszadeh-Ahranjani S, Shahbazi S, Khooshehchin G, Bandarian F, et al. Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial. Daru 2012, 20(1):10. 10.1186/2008-2231-20-10, 23351271.
22. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, et al. Daily consumption of vitamin D or vitamin D calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. AmJ Clin Nutr 2011, 93(4):764-71. 10.3945/ajcn.110.007336.
23. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 2011, 9:125. 10.1186/1741-7015-9-125, 22114787.
24. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535. 10.1136/bmj.b2535, 19622551.
25. Wells GS, B O'Connell, D Peterson, J Welch, V Losos, M Tugwell. P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis.2011. Access date: July 2014. www.ohri.ca/programs/clinical_epidemiology/oxford.htm..
26. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 1996, 17(1):1-12. 10.1016/0197-2456(95)00134-4, 8721797.
27. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57(4):258-61. 12800453.
28. Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract 2010, 16(4):600-8. 10.4158/EP09300.OR, 20350923.
29. Witham MD, Dove FJ, Dryburgh M, Morris AD, Struthers AD. The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes-a randomised controlled trial. Diabetologia 2010, 53:2112-9. 10.1007/s00125-010-1838-1, 20596692.
30. Soric MM, Renner ET, Smith SR. Effect of daily vitamin D supplementation on HbA1c in patients with uncontrolled type 2 diabetes mellitus: a pilot study. J Diab 2012, 4(1):104-5. 10.1111/j.1753-0407.2011.00164.x.
31. Yiu YF, Yiu KH, Siu CW, Chan YH, Li SW, Wong LY, et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227(1):140-6. 10.1016/j.atherosclerosis.2012.12.013, 23298824.
32. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 2009, 48(6):349-54. 10.1007/s00394-009-0020-3, 19370371.
33. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008, 25(3):320-5. 10.1111/j.1464-5491.2007.02360.x, 18279409.
34. Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial. J Diab 2010, 2(1):36-40. 10.1111/j.1753-0407.2009.00057.x.
35. Sabherwal S, Bravis V, Devendra D. Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int J Clin Pract 2010, 64(8):1084-9. 10.1111/j.1742-1241.2010.02372.x, 20642708.
36. Kota SK, Jammula S, Kota SK, Tripathy PR, Panda S, Modi KD. Effect of vitamin supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diab Metab Syndr 2011, 5(2):85-9. 10.1016/j.dsx.2012.02.021.
37. Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hasanzadeh J. Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr 2011, 20(4):521-6. 22094836.
38. Jehle S, Lardi A, Felix B, Hulter HN, Stettler C, Krapf R. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study. Swiss Med Wkly 2014, 144:w13942. 24652692.
39. Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A. Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 2014, 57(10):2038-47. 10.1007/s00125-014-3313-x, 25005333.
40. Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L et al. Effects of 12weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency- a double-blind, randomized, placebo-controlled trial. Metabolism. 2014. doi:10.1016/j.metabol.2014.06.008.
41. Krul-Poel YH, Wijland H, Stam F, Ten Boekel E, Lips P, Simsek S. Studyprotocol: a randomised placebo-controlled clinical trial to study the effect of vitamin D supplementation on glycaemic control in type 2 Diabetes Mellitus SUNNY trial. BMC Endocr Disord 2014, 14:59. 10.1186/1472-6823-14-59, 25033925.
42. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, et al. Effect of Vitamin D (3) Supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2014, 99(10):3551-60. 10.1210/jc.2014-2136, 25062463.
43. Gao W, Chen DW, Liu GJ, Ran XW. Efficacy and safety of vitamin D for type 2 diabetes mellitus: a systematic review. Zhonghua Yi Xue Za Zhi 2013, 93(18):1401-6. 24025505.
44. Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 2013, 72(1):89-97. 10.1017/S0029665112002765, 23107484.
45. Jorde R, Strand Hutchinson M, Kjærgaard M, Sneve M, Grimnes G. Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromsø. ISRN Endocrinol 2013, 2013:348705. 10.1155/2013/348705, 23577264.
46. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH, et al. Treatment with 1α-hydroxycholecalciferol in middle-aged men with impaired glucose-tolerance- a prospective randomized double-blind-study. Acta Med Scand 1987, 222:361-7. 10.1111/j.0954-6820.1987.tb10684.x, 3321925.
47. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92(6):2017-29. 10.1210/jc.2007-0298, 17389701.
48. Kumar S, Davies M, Zakaria Y, Mawer EB, Gordon C, Olukoga AO, et al. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J 1994, 70(824):440-3. 10.1136/pgmj.70.824.440, 8029165.
49. Neyestani TR, Djazayery A, Shab-Bidar S, Eshraghian MR, Kalayi A, Shariátzadeh N, et al. Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care 2013, 36(3):550-6. 10.2337/dc12-0919, 23160722.